» Articles » PMID: 36458002

Antiviral Response Within Different Cell Types of the CNS

Overview
Journal Front Immunol
Date 2022 Dec 2
PMID 36458002
Authors
Affiliations
Soon will be listed here.
Abstract

The central nervous system (CNS) is a constitutive structure of various cell types conserved by anatomical barriers. Many of the major CNS cell-type populations distributed across the different brain regions are targets for several neurotropic viruses. Numerous studies have demonstrated that viral susceptibility within the CNS is not absolute and initiates a cell-type specific antiviral defence response. Neurons, astrocytes, and microglial cells are among the major resident cell populations within the CNS and are all equipped to sense viral infection and induce a relative antiviral response mostly through type I IFN production, however, not all these cell types adopt a similar antiviral strategy. Rising evidence has suggested a diversity regarding IFN production and responsiveness based on the cell type/sub type, regional distinction and cell`s developmental state which could shape distinct antiviral signatures. Among CNS resident cell types, neurons are of the highest priority to defend against the invading virus due to their poor renewable nature. Therefore, infected and uninfected glial cells tend to play more dominant antiviral roles during a viral infection and have been found to be the major CNS IFN producers. Alternatively, neuronal cells do play an active part during antiviral responses but may adopt differential strategies in addition to induction of a typical type I IFN response, to minimize the chance of cellular damage. Heterogeneity observed in neuronal IFN responsiveness may be partially explained by their altered ISGs and/or lower STATS expression levels, however, further studies are required to fully elucidate the specificity of the acquired antiviral responses by distinct CNS cell types.

Citing Articles

Bystander neuronal progenitors in forebrain organoids promote protective antiviral responses.

Negatu S, Vazquez C, Bannerman C, Amses K, Ming G, Jurado K J Neuroinflammation. 2025; 22(1):65.

PMID: 40045355 PMC: 11881317. DOI: 10.1186/s12974-025-03381-y.


Antiviral immunity within neural stem cells distinguishes Enterovirus-D68 strain differences in forebrain organoids.

Vazquez C, Negatu S, Bannerman C, Sriram S, Ming G, Jurado K J Neuroinflammation. 2024; 21(1):288.

PMID: 39501367 PMC: 11539839. DOI: 10.1186/s12974-024-03275-5.


CNS disease associated with enhanced type I interferon signalling.

Crow Y Lancet Neurol. 2024; 23(11):1158-1168.

PMID: 39424561 PMC: 7616788. DOI: 10.1016/S1474-4422(24)00263-1.


Co-option of mitochondrial nucleic acid sensing pathways by HSV-1 UL12.5 for reactivation from latent Infection.

Cuddy S, Flores M, Krakowiak P, Whitford A, Dochnal S, Babnis A bioRxiv. 2024; .

PMID: 39005440 PMC: 11245091. DOI: 10.1101/2024.07.06.601241.


The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis.

Griesman T, McMillen C, Negatu S, Hulahan J, Whig K, Dohnalova L PLoS Pathog. 2024; 20(6):e1012343.

PMID: 38935789 PMC: 11236204. DOI: 10.1371/journal.ppat.1012343.


References
1.
Menager P, Roux P, Megret F, Bourgeois J, Le Sourd A, Danckaert A . Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 2009; 5(2):e1000315. PMC: 2642728. DOI: 10.1371/journal.ppat.1000315. View

2.
Drokhlyansky E, Goz Ayturk D, Soh T, Chrenek R, OLoughlin E, Madore C . The brain parenchyma has a type I interferon response that can limit virus spread. Proc Natl Acad Sci U S A. 2016; 114(1):E95-E104. PMC: 5224383. DOI: 10.1073/pnas.1618157114. View

3.
Monson E, Crosse K, Duan M, Chen W, OShea R, Wakim L . Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response. Nat Commun. 2021; 12(1):4303. PMC: 8280141. DOI: 10.1038/s41467-021-24632-5. View

4.
Davalos D, Grutzendler J, Yang G, Kim J, Zuo Y, Jung S . ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005; 8(6):752-8. DOI: 10.1038/nn1472. View

5.
Schoggins J, Rice C . Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2012; 1(6):519-25. PMC: 3274382. DOI: 10.1016/j.coviro.2011.10.008. View